Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Stock Information | RedChip

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Listen to this Section


$5.58
N/A ( 0% ) 41.9K

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market Data


Open


$5.58

Previous close


$5.58

Volume


41.9K

Market cap


$152.15M

Day range


$5.55 - $5.69

52 week range


$5.26 - $11.92

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 59 Aug 07, 2023
4 Insider transactions 1 Aug 07, 2023
8-k 8K-related 14 Aug 04, 2023
8-k 8K-related 16 Aug 04, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.